导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.38% | 852/3241 |
| 近一周 | 0.04% | 2684/3518 |
| 近一月 | 0.10% | 415/3513 |
| 近一季 | 0.58% | 535/3484 |
| 近半年 | 0.53% | 1018/3397 |
| 近一年 | 1.81% | 775/3200 |
| 近两年 | 6.00% | 1426/2673 |
| 近三年 | 11.37% | 603/2296 |
| 成立以来 | 23.46% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-0.06% 994/3040 |
1.01% 1244/3451 |
-0.18% 1358/3497 |
- - |
| 2024 | 4.12% 1844/3316 |
1.12% 1758/3226 |
1.28% 1223/3360 |
-0.09% 2766/3195 |
1.75% 1754/3316 |
| 2023 | 5.34% 287/3108 |
1.27% 768/2776 |
1.10% 1697/2849 |
1.40% 56/2940 |
1.47% 186/3108 |
| 2022 | 2.21% 1337/2727 |
0.56% 843/1949 |
1.06% 786/2522 |
0.81% 1880/2598 |
-0.23% 1350/2732 |
| 2021 | 4.02% 1062/2409 |
0.96% 431/2068 |
1.05% 1105/2668 |
1.24% 947/2731 |
0.72% 1981/2416 |
| 2020 | 2.14% 1301/2196 |
2.30% 464/1576 |
-0.51% 1249/2274 |
-0.33% 1590/2475 |
0.68% 1776/2563 |
| 2019 | - - |
- - |
- - |
0.89% 1265/1762 |
1.02% 890/1956 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 国泰瑞安三个月定期开放债券 VS. () |